Financhill
Buy
76

DBOEY Quote, Financials, Valuation and Earnings

Last price:
$29.66
Seasonality move :
3.28%
Day range:
$29.20 - $29.70
52-week range:
$19.11 - $29.70
Dividend yield:
1.39%
P/E ratio:
25.88x
P/S ratio:
7.18x
P/B ratio:
4.86x
Volume:
100.8K
Avg. volume:
235.3K
1-year change:
45.18%
Market cap:
$54.5B
Revenue:
$7.6B
EPS (TTM):
$1.15
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.2B $5.2B $5.5B $6.6B $7.6B
Revenue Growth (YoY) 14.8% 21.61% 6.74% 19.76% 15.18%
 
Cost of Revenues $1.8B $2.5B $2.4B $2.7B $3.2B
Gross Profit $2.4B $2.7B $3.2B $3.9B $4.4B
Gross Profit Margin 56.63% 51.56% 57.32% 59.17% 58.35%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $42.5M $53.2M $55.5M $64.2M $70.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $598.8M $695.4M $881.5M $1.2B $1.3B
Operating Income $1.8B $2B $2.3B $2.7B $3.1B
 
Net Interest Expenses $87.8M $47.3M $72.2M $84.1M $153.3M
EBT. Incl. Unusual Items $1.7B $2B $2.2B $2.7B $3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $460.4M $525.8M $573M $709M $756.5M
Net Income to Company $1.3B $1.5B $1.6B $1.9B $2.2B
 
Minority Interest in Earnings -$51.6M -$65.3M -$72.6M -$78.8M -$106M
Net Income to Common Excl Extra Items $1.2B $1.4B $1.6B $1.9B $2.1B
 
Basic EPS (Cont. Ops) $0.67 $0.78 $0.86 $1.01 $1.15
Diluted EPS (Cont. Ops) $0.67 $0.78 $0.86 $1.01 $1.15
Weighted Average Basic Share $1.8B $1.8B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.8B $1.8B $1.8B $1.8B $1.8B
 
EBITDA $2.2B $2.5B $2.7B $3.2B $3.7B
EBIT $1.9B $2.1B $2.3B $2.8B $3.2B
 
Revenue (Reported) $4.2B $5.2B $5.5B $6.6B $7.6B
Operating Income (Reported) $1.8B $2B $2.3B $2.7B $3.1B
Operating Income (Adjusted) $1.9B $2.1B $2.3B $2.8B $3.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.2B $1.3B $1.5B $1.9B $2B
Revenue Growth (YoY) 24.81% 13.77% 8.59% 27.6% 6.77%
 
Cost of Revenues $792M $783.4M $628.9M $815.5M $842.1M
Gross Profit $384M $554.6M $824M $1B $1.1B
Gross Profit Margin 32.65% 41.45% 56.72% 56.01% 57.46%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -$32.2M $98.9M $279.3M $370.5M $368.7M
Operating Income $416.2M $455.7M $544.8M $667.9M $768.6M
 
Net Interest Expenses $31.2M $12.7M $13.2M $50.9M $19.7M
EBT. Incl. Unusual Items $397.8M $463.2M $517.5M $630.4M $757.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $108.9M $120.4M $130.1M $170M $188.4M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$16M -$21.2M -$20.1M -$21.8M -$28M
Net Income to Common Excl Extra Items $272.9M $321.6M $367.3M $438.5M $540.9M
 
Basic EPS (Cont. Ops) $0.15 $0.17 $0.20 $0.24 $0.29
Diluted EPS (Cont. Ops) $0.15 $0.17 $0.20 $0.24 $0.29
Weighted Average Basic Share $1.8B $1.8B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.8B $1.8B $1.8B $1.9B $1.8B
 
EBITDA $547.6M $691.3M $675.5M $832.9M $972.7M
EBIT $455.9M $590.4M $576.3M $697.8M $835.6M
 
Revenue (Reported) $1.2B $1.3B $1.5B $1.9B $2B
Operating Income (Reported) $416.2M $455.7M $544.8M $667.9M $768.6M
Operating Income (Adjusted) $455.9M $590.4M $576.3M $697.8M $835.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.2B $5.2B $5.5B $6.6B $7.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2B $2.6B $2.5B $2.9B $3.4B
Gross Profit $2.3B $2.6B $3B $3.7B $4.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $494.2M $592.8M $706.3M $960.1M $1.1B
Operating Income $1.8B $2B $2.3B $2.7B $3.1B
 
Net Interest Expenses $88.2M $47.4M $71.7M $83.8M $153.7M
EBT. Incl. Unusual Items $1.7B $2B $2.2B $2.7B $3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $458.3M $526.2M $574.1M $708.8M $756.3M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$51.6M -$65.1M -$72.5M -$78.8M -$105.9M
Net Income to Common Excl Extra Items $1.2B $1.4B $1.6B $1.9B $2.1B
 
Basic EPS (Cont. Ops) $0.67 $0.78 $0.86 $1.01 $1.15
Diluted EPS (Cont. Ops) $0.67 $0.78 $0.86 $1.01 $1.15
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.2B $2.5B $2.7B $3.2B $3.7B
EBIT $1.9B $2.2B $2.4B $2.8B $3.2B
 
Revenue (Reported) $4.2B $5.2B $5.5B $6.6B $7.6B
Operating Income (Reported) $1.8B $2B $2.3B $2.7B $3.1B
Operating Income (Adjusted) $1.9B $2.2B $2.4B $2.8B $3.2B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $5.2B $5.5B $6.6B $7.6B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.6B $2.5B $2.9B $3.4B --
Gross Profit $2.6B $3B $3.7B $4.2B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11.2M -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $592.8M $706.3M $960.1M $1.1B --
Operating Income $2B $2.3B $2.7B $3.1B --
 
Net Interest Expenses $47.4M $71.7M $83.8M $153.7M --
EBT. Incl. Unusual Items $2B $2.2B $2.7B $3B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $526.2M $574.1M $708.8M $756.3M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$65.1M -$72.5M -$78.8M -$105.9M --
Net Income to Common Excl Extra Items $1.4B $1.6B $1.9B $2.1B --
 
Basic EPS (Cont. Ops) $0.78 $0.86 $1.01 $1.15 --
Diluted EPS (Cont. Ops) $0.78 $0.86 $1.01 $1.15 --
Weighted Average Basic Share $7.3B $7.3B $7.4B $7.3B --
Weighted Average Diluted Share $7.3B $7.4B $7.4B $7.4B --
 
EBITDA $2.5B $2.7B $3.2B $3.7B --
EBIT $2.2B $2.4B $2.8B $3.2B --
 
Revenue (Reported) $5.2B $5.5B $6.6B $7.6B --
Operating Income (Reported) $2B $2.3B $2.7B $3.1B --
Operating Income (Adjusted) $2.2B $2.4B $2.8B $3.2B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.6B $3.3B $2B $2.3B $2.5B
Short Term Investments $107.2B $122.3B $140B $153B $133.2B
Accounts Receivable, Net $758.4M $1.1B $2.5B $2B $1.3B
Inventory -- -- -- -- --
Prepaid Expenses $83.1M $105.3M $137.2M $140.3M $141.5M
Other Current Assets $13.2M $48.3M $40.9M $19.1M $23.1M
Total Current Assets $169.9B $229.2B $266.1B $236.9B $207.9B
 
Property Plant And Equipment $652.4M $672.2M $676.9M $669.4M $712.9M
Long-Term Investments -- -- -- -- --
Goodwill $4.9B $6.3B $6.3B $9.1B $8.7B
Other Intangibles $2.2B $2.9B $2.9B $4.7B $4.5B
Other Long-Term Assets $7.3M $18.9M $22.6M $315.6M $375.4M
Total Assets $187.8B $252.4B $288.4B $262.8B $231.1B
 
Accounts Payable $478M $797.5M $2.2B $1.7B $934.7M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $62.9M $72M $75.9M $94M $76.8M
Other Current Liabilities $519.9M $2.9B $2.3B $816.8M $1.1B
Total Current Liabilities $166.2B $228.2B $263.4B $233.7B $204.3B
 
Long-Term Debt $3.2B $3.4B $4.4B $7.8B $6.5B
Capital Leases -- -- -- -- --
Total Liabilities $179.7B $243.6B $278.7B $251.6B $219.4B
 
Common Stock $233.7M $215.1M $203.8M $210M $195.9M
Other Common Equity Adj -- -- -- -- --
Common Equity $7.6B $8.2B $9.1B $10.7B $11.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $477M $604.9M $631.8M $484.9M $508.5M
Total Equity $8.1B $8.8B $9.7B $11.2B $11.7B
 
Total Liabilities and Equity $187.8B $252.4B $288.4B $262.8B $231.1B
Cash and Short Terms $111.8B $125.6B $142B $155.3B $135.7B
Total Debt $5.4B $6.6B $5.2B $9.1B $9.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.6B $3.3B $2B $2.3B $2.5B
Short Term Investments $107.2B $122.3B $140B $153B $133.2B
Accounts Receivable, Net $758.4M $1.1B $2.5B $2B $1.3B
Inventory -- -- -- -- --
Prepaid Expenses $83.1M $105.3M $137.2M $140.3M $141.5M
Other Current Assets $13.2M $48.3M $40.9M $19.1M $23.1M
Total Current Assets $169.9B $229.2B $266.1B $236.9B $207.9B
 
Property Plant And Equipment $652.4M $672.2M $676.9M $669.4M $712.9M
Long-Term Investments -- -- -- -- --
Goodwill $4.9B $6.3B $6.3B $9.1B $8.7B
Other Intangibles $2.2B $2.9B $2.9B $4.7B $4.5B
Other Long-Term Assets $7.3M $18.9M $22.6M $315.6M $375.4M
Total Assets $187.8B $252.4B $288.4B $262.8B $231.1B
 
Accounts Payable $478M $797.5M $2.2B $1.7B $934.7M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $62.9M $72M $75.9M $94M $76.8M
Other Current Liabilities $519.9M $2.9B $2.3B $816.8M $1.1B
Total Current Liabilities $166.2B $228.2B $263.4B $233.7B $204.3B
 
Long-Term Debt $3.2B $3.4B $4.4B $7.8B $6.5B
Capital Leases -- -- -- -- --
Total Liabilities $179.7B $243.6B $278.7B $251.6B $219.4B
 
Common Stock $233.7M $215.1M $203.8M $210M $195.9M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $477M $604.9M $631.8M $484.9M $508.5M
Total Equity $8.1B $8.8B $9.7B $11.2B $11.7B
 
Total Liabilities and Equity $187.8B $252.4B $288.4B $262.8B $231.1B
Cash and Short Terms $111.8B $125.6B $142B $155.3B $135.7B
Total Debt $5.4B $6.6B $5.2B $9.1B $9.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $1.3B $1.5B $1.6B $1.9B $2.2B
Depreciation & Amoritzation $301.8M $347.5M $375M $453.1M $536.6M
Stock-Based Compensation -- -- -- -- $54.8M
Change in Accounts Receivable $734.6M $2.3B -$1.6B -$1.7B $835.8M
Change in Inventories -- -- -- -- --
Cash From Operations $1.6B $1.1B $2.6B $2.8B $2.6B
 
Capital Expenditures $223.3M $244.2M $343M $290M $390.3M
Cash Acquisitions -$519.3M -$2.2B -$181.3M -$4.2B -$12.9M
Cash From Investing -$899.6M -$2.6B -$1.5B -$4.3B -$64.9M
 
Dividends Paid (Ex Special Dividend) -$607.4M -$651.5M -$619.7M -$716.1M -$755.3M
Special Dividend Paid
Long-Term Debt Issued $1.1B $4.4B $2.3B $3.4B --
Long-Term Debt Repaid -$688.5M -$2.7B -$2.5B -$182.4M -$240.6M
Repurchase of Common Stock -- -- -- -- -$322.3M
Other Financing Activities -$30.4M -$48.4M -- $138.8M --
Cash From Financing -$290.3M $945M -$1B $2.5B -$1.5B
 
Beginning Cash (CF) $2.5B $3B $2.1B $2.3B $3.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $422.7M -$544.7M $132.9M $915.1M $1.1B
Ending Cash (CF) $2.9B $2.4B $2.2B $3.2B $4.2B
 
Levered Free Cash Flow $1.4B $831.2M $2.3B $2.5B $2.2B
Period Ending 2011-12-31 2012-12-31 2013-12-31 2014-12-31 2015-12-31
Net Income to Stockholders $196.8M $230.5M $174M $308.7M $116.2M
Depreciation & Amoritzation $32.6M $39.5M $41.7M $43M $47.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $266.9M -$22.6M -$35.6M -$401.2M -$799.2M
Change in Inventories -- -- -- -- --
Cash From Operations $199.2M $224.2M $254.9M $263.1M -$807.1M
 
Capital Expenditures $54.8M $77.1M $56M $67.1M $57.3M
Cash Acquisitions $34.4M $16.5M -$6.6M -$77.3M -$765.5M
Cash From Investing -$210.3M $461.5M -$120M -$470.9M -$797M
 
Dividends Paid (Ex Special Dividend) $7.4M -$22.1M -$997.7K -$1.8M $631.9K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $799.4M $296.4M $257.1M $976.2M
Long-Term Debt Repaid $95.2K -$794.5M -$502.2M -$297.1M -$457.6M
Repurchase of Common Stock -$155.7M -$130.5M -$3.1K -- --
Other Financing Activities -$34.3K $482.6K -$21.4K -$738.9K -$12.5M
Cash From Financing -$148.2M -$145.8M -$206.7M -$42.4M $507M
 
Beginning Cash (CF) $1.1B $141.4M -$1.6M $157.6M -$658M
Foreign Exchange Rate Adjustment $4.4M -$5.2M -$2.7M $1.9M $2.3M
Additions / Reductions -$159.4M $539.9M -$71.8M -$250.3M -$1.1B
Ending Cash (CF) $916.3M $699.4M -$74.6M -$91.1M -$1.8B
 
Levered Free Cash Flow $144.4M $147.2M $198.9M $196M -$864.4M
Period Ending 2012-09-30 2013-09-30 2014-09-30 2015-09-30 2016-09-30
Net Income to Stockholders $827.4M $714.2M $913.9M $970.6M --
Depreciation & Amoritzation $128.1M $155.6M $164.6M $155.2M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $259.7M -$93.2M -$94.7M -$136.1M --
Change in Inventories -- -- -- -- --
Cash From Operations $884.8M $936.6M $892.5M $1.1B --
 
Capital Expenditures $165M $190.5M $166.4M $181.3M $57.3M
Cash Acquisitions -$336.8M -$16.7M $72.3M -$45.1M -$765.5M
Cash From Investing -$1B -$519.8M $18M -$1.4B --
 
Dividends Paid (Ex Special Dividend) -$771.3M -$534.4M -$513.3M -$431.6M $631.9K
Special Dividend Paid
Long-Term Debt Issued $986.8M $3B $1.6B $2.8B --
Long-Term Debt Repaid -$626.5M -$2.9B -$1.8B -$2.3B --
Repurchase of Common Stock -$280M -$132.1M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$710.3M -$599.9M -$750.9M -$465M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$841.1M -$183.1M $159.6M -$824.5M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $719.7M $746.1M $726.1M $900.1M --
Period Ending 2021-04-01 2022-04-01 2023-04-01 2024-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock